Assignment of the human melanoma inhibitory activity gene (MIA) to 19q13.32-q13.33 by fluorescence in situ hybridization (FISH)

Genomics

Volumn 35, Issue 1, 1996, Pages 265-267

  Koehler, M R ^a   Bosserhoff, A K ^b   Von Beust, G ^a   Bauer, A ^a   Blesch, A ^a   Buettner, R ^b   Schlegel, J ^b   Bogdahn, U ^a   Schmid, M ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GROWTH; CHROMOSOME 19Q; FLUORESCENCE IN SITU HYBRIDIZATION; MELANOMA; ONTOGENY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0030200902     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1996.0352     Document Type: Article

References (22)

1. 1. Albino, A. P., Davis, B. M., and Nanus, D. M. (1991). Induction of growth factor RNA expression in human malignant melanoma: Markers of transformation. Cancer Res. 51: 4815-4820.
2. 2. Apfel, R., Lottspeich, F., Hoppe, J., Behl, C., Dürr, G., and Bogdahn, U. (1992). Purification and analysis of growth regulating proteins secreted by a human melanoma cell line. Melanoma Res. 2: 327-336.
3. 3. Blesch, A., Boßerhoff, A.-K, Apfel, R., Behl, C., Hessdoerfer, B., Schmitt, A., Jachimczak, P., Lottspeich, F., Buettner, R., and Bogdahn, U. (1994). Cloning of a novel malignant melanoma-derived growth-regulatory protein, MIA. Cancer Res. 54: 5695-5701.
4. 4. Bogdahn, U., Apfel, R., Hahn, M., Gerlach, M., Behl, C., Hoppe, J., and Martin, R. (1989). Autocrine tumor cell growth inhibiting activities from human malignant melanoma. Cancer Res. 49: 5358-5363.
5. 5. Bordoni, R., Fine, R., Murray, D., and Richmond, A. (1990). Characterization of the role of melanoma growth stimulatory activity (MGSA) in the growth of normal melanocytes, nevocytes, and malignant melanocytes. J. Cell. Biochem. 44: 207-219.
6. 6. Brozena, S. J., Fenske, N. A., and Perez, I. R. (1993). Epidemiology of malignant melanoma, worldwide incidence, and etiologic factors. Semin. Surg. Oncol. 9: 165-167.
7. 7. Francke, U. (1994). Digitized and differentially shaded human chromosome ideograms for genomic applications. Cytogenet. Cell Genet. 65: 206-219.
8. 8. Halaban, R., Known, B. S., Ghosh, S., Delli Bovi, P., and Baird, A. (1988). bFGF as an autocrine growth factor for human melanomas. Oncogene Res. 3: 177-186.
9. 9. Köhler, M. R., and Vogt, P. H. (1994). Interstitial deletions of repetitive DNA blocks in dicentric human Y chromosomes. Chromosoma 103: 324-330.
10. 10. Levy, E., Silverman, M. K., Vossaert, K. A., Kopf, A. W., Bart, R. S., Golomb, F. M., Levenstein, M. J. (1991). Late recurrence of malignant melanoma: a report of five cases, a review of the literature and a study of associated factors. Melanoma Res. 1: 63-67.
11. 11. Lu, C., Vickers, M. F., Kerbel, R. (1992). Interleukin 6: a fibroblast-derived growth inhibitor of human melanoma cells from early but not advanced stages of tumor progression. Proc. Natl. Acad. Sci. USA 89: 9215-9219.
12. 12. Lu, C., Rak, J. W., Koboyashi, H., Kerbel, R. (1993). Increased resistance to Oncostatin M-induced growth inhibition of human melanoma cell lines derived from advanced-stage lesions. Cancer Res. 53: 2708-2711.
13. 13. Lu, C., Kerbel, R. S. (1993). Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression. J. Cell Biol. 120: 1281-1288.
14. 14. Menrad, A., and Herlyn, M. (1992). Tumor progression, biology, and host response in melanoma. Curr. Opin. Oncol. 4: 351-356.
15. 15. Osterlind, A. (1992). Epidemiology on malignant melanoma in Europe. Acta Oncol. 31: 903-908.
16. 16. Pinkel, D., Straume, T., Gray, J. W. (1986). Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proc. Natl. Acad. Sci. USA 83: 2934-2938.
17. 17. Rodeck, U., Bossler, A., Graeven, U., Fox, F. E., Nowell, P. C., Knabbe, C., Kari, C. (1994). Transforming growth factor-β production and responsivness in normal human melanocytes and melanoma cells. Cancer Res. 54: 575-581.
18. 18. Rubio, M. P., Correa, K. M., Ueki, K., Mohrenweiser, H. W., Gusella, J. F., von Deimling, A., Louis, D. N. (1994). The putative glioma tumor suppressor gene on chromosome 19q maps between APOC2 and HRC. Cancer Res. 54: 4760-4763.
19. 19. Schweizer, D. (1976). Reverse fluorescent chromosome banding with chromomycin and DAPI. Chromosoma 58: 307-324.
20. 20. Shoyab, M., Gentry, L. E., Marquard, H., Todaro, G. J. (1986). Isolation and characterization of a putative endogenous benzodiazeepineoid (endozepine) from bovine and human brain. J. Biol. Chem. 261: 11968-11973.
21. 21. Stetler-Stevenson, W. G., Krutzsch, H. C., Liotta, L. A. (1989). Tissue inhibitor of metalloproteinase. J. Biol. Chem. 264: 17374-17378.
22. 22. Von Deimling, A., Bender, B., Jahnke, R., Waha, A., Kraus, J., Albrecht, S., Wellenreuther, R., Fassbender, F., Nagel, J., et al. (1994). Loci associated with malignant progression in astrocytomas: A candidate on chromosome 19q. Cancer Res. 54: 1397-1401.